RGEN Q1 2023 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

Q1 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$165M-19.9% YoY

Gross Profit

$84M50.5% margin

Operating Income

$14M8.4% margin

Net Income

$15M9.3% margin

EPS (Diluted)

$0.51

QoQ Revenue Growth

-11.4%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$2M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$598M

Stockholders' Equity

$1.9B

Cash & Equivalents

$517M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$165M	$206M	-19.9%
Gross Profit	$84M	$124M	-32.7%
Operating Income	$14M	$60M	-76.9%
Net Income	$15M	$47M	-67.3%

Revenue Segments

Product

$183M100%

Royalty

$39,0000%